Written by Keen Meds  ·  Reviewed by Licensed Clinical Providers  ·  March 1, 2026

Key Insight: Low testosterone is associated with increased visceral adiposity -- the metabolically dangerous fat around the organs -- independent of total body weight.

> Low testosterone is associated with increased visceral adiposity -- the metabolically dangerous fat around the organs -- independent of total body weight.

Medically reviewed by licensed clinical providers · March 2026

Men who gain weight in their 40s are typically told the same things: eat less, move more, accept that metabolism slows with age. That advice is not wrong. But it is incomplete. A significant and underappreciated driver of weight gain and body composition change in middle-aged men is testosterone decline. Testosterone has direct effects on fat distribution, insulin sensitivity, lean muscle mass, and metabolic rate. When it falls below clinical levels, those effects become clinically meaningful -- and addressing them requires more than dietary discipline alone. This post explains the hormonal mechanisms behind male weight gain and what the clinical evidence shows about testosterone's role.

The Testosterone-Fat Feedback Loop

The relationship between testosterone and body fat is bidirectional, which is what makes it particularly difficult to interrupt without clinical intervention.

When testosterone falls, the body shifts toward fat storage and away from lean tissue synthesis. Testosterone is anabolic -- it promotes protein synthesis in muscle and signals the body to use energy for tissue building. When levels decline, this anabolic signal weakens, and caloric energy is more readily directed to fat storage, particularly visceral fat.

Here is where the feedback loop forms. Adipose tissue -- fat cells -- contains the enzyme aromatase, which converts testosterone into estradiol (estrogen). The more visceral fat a man carries, the higher his aromatase activity, and the more testosterone is converted to estrogen. Elevated estrogen in men feeds back to suppress the HPG axis (hypothalamic-pituitary-gonadal axis), reducing the pituitary signal to the testes and further lowering testosterone production.

The result is a self-reinforcing cycle: low testosterone promotes fat accumulation, fat tissue converts testosterone to estrogen, estrogen suppresses testosterone production, and testosterone falls further. Men can enter this cycle gradually through normal age-related testosterone decline and exit it only with deliberate hormonal or metabolic intervention.

Visceral Fat vs. Subcutaneous Fat: Why It Matters Clinically

Not all fat carries equal metabolic risk. The fat that accumulates preferentially in hypogonadal men is visceral adiposity -- fat deposited around the intra-abdominal organs (liver, pancreas, intestines, kidneys). Visceral fat is metabolically active in ways that subcutaneous fat (fat under the skin) is not.

Visceral fat releases inflammatory cytokines, contributes to insulin resistance, raises cardiovascular risk markers, and drives aromatase-mediated testosterone conversion. Men can appear to have a modest waist circumference while carrying significant visceral fat, particularly in the early stages of accumulation.

The clinical association between low testosterone and visceral adiposity holds independent of total body weight. In other words, men with low testosterone accumulate disproportionately dangerous fat even when the scale does not show dramatic weight change. This is one reason waist circumference is a more clinically meaningful indicator than weight alone in middle-aged men.

Testosterone, Insulin Sensitivity, and Metabolic Function

Testosterone improves insulin sensitivity through multiple mechanisms. It increases GLUT4 receptor expression in skeletal muscle, which enhances glucose uptake from the bloodstream. It reduces hepatic lipid accumulation and improves pancreatic beta-cell function. In hypogonadal men, insulin resistance is common and often precedes frank metabolic syndrome.

The T4DM trial (Testosterone for Diabetes Mellitus, published in The Lancet Diabetes and Endocrinology) provided some of the strongest evidence for this relationship. The trial randomized men at high risk for type 2 diabetes to testosterone undecanoate or placebo over two years. Men receiving testosterone had a significantly lower rate of new diabetes diagnosis (12% vs. 21%) compared to placebo. The effect was attributed to improvements in insulin sensitivity and a reduction in visceral fat mass.

This finding matters for men who are gaining weight, developing prediabetes markers, or accumulating central adiposity. Hormonal status is a clinically relevant factor in metabolic risk evaluation.

What TRT Does for Body Composition

Clinical evidence supports the following body composition effects of testosterone therapy in hypogonadal men:

Lean muscle mass increases. Multiple randomized trials show TRT produces modest but measurable gains in lean body mass, even without a formal resistance training program. With training, the effect is more pronounced.

Fat mass decreases. TRT is associated with reductions in total and visceral fat mass over 12 to 24 months. The effect is gradual and not dramatic. Men should not expect a rapid transformation; the typical finding is a shift in body composition rather than large absolute weight loss.

Metabolic markers improve. Studies show improvements in fasting insulin, hemoglobin A1c, and lipid profiles in some hypogonadal men on TRT.

Functional capacity improves. Increased lean mass and reduced fatigue translate to better exercise capacity, which further supports body composition change over time.

It is essential to be direct about what TRT does not do. It is not a weight loss drug. Men who begin TRT and continue poor dietary habits and sedentary behavior will see attenuated or absent body composition changes. TRT corrects a hormonal deficit that impairs normal metabolic function -- but behavior and physiology must both contribute to meaningful results. The appropriate framing is hormonal optimization that restores the body's capacity to respond normally to diet and exercise, not a standalone intervention.

Setting Realistic Expectations

The clinical evidence suggests body composition changes with TRT develop over 6 to 18 months, with the most measurable shifts in visceral fat and lean mass emerging after 6 months of stable therapeutic levels. Some men see changes earlier; others require longer timelines depending on baseline testosterone, degree of insulin resistance, and activity level.

A testosterone evaluation is appropriate for men over 35 who are experiencing unexplained weight gain, particularly central adiposity, alongside other symptoms of hypogonadism. Evaluation involves a morning fasting testosterone test; a diagnosis of hypogonadism requires two separate measurements below 300 ng/dL along with clinical symptoms.

Frequently Asked Questions

Can low testosterone cause belly fat even if I exercise regularly?
Yes. The aromatase feedback loop and insulin resistance associated with hypogonadism can produce visceral fat accumulation even in physically active men. Men who are exercising consistently but losing ground on body composition despite reasonable dietary habits are appropriate candidates for a hormone evaluation. Training response may also be blunted by low testosterone, reducing the effectiveness of the same effort that previously produced results.

Will TRT help me lose weight?
TRT is associated with reductions in fat mass -- particularly visceral fat -- in men with confirmed hypogonadism, but it is not a weight loss medication in the conventional sense. The body composition changes it produces (increased lean mass, decreased fat mass) may not translate to significant scale weight reduction. Most men see changes in how their body looks and how clothes fit before seeing large changes on the scale. TRT works best as part of a broader approach that includes physical activity and appropriate nutrition.

Does the relationship between testosterone and weight work in reverse? Does being overweight lower testosterone?
Yes. This is the bidirectional relationship described above. Excess body fat -- particularly visceral fat -- raises aromatase activity, converts testosterone to estrogen, and suppresses HPG axis testosterone production. Both directions of the relationship are clinically real. Weight loss through diet and exercise can modestly raise testosterone in overweight hypogonadal men, but for many, testosterone levels do not fully normalize with lifestyle changes alone, and clinical evaluation is warranted.

Is Weight Gain Part of Your Low Testosterone Picture?

If unexplained weight gain -- particularly around the abdomen -- is part of a pattern alongside fatigue, reduced muscle response to training, or low libido, low testosterone may be a contributing factor. A blood test is the only way to confirm.

Keen Meds connects you with a licensed clinical team for a telehealth consultation and lab review. If your testosterone is clinically low, you receive a prescription for Testosterone Spray Rx -- delivered via Hypospray®, Keen's needle-free transdermal spray platform.

Start your Keen Testosterone Spray Program →

Medically reviewed by Licensed Clinical Providers · March 2026

Related reading: